Abbott’s acquisition of Alere: reshaping the market for rapid medical tests

by

Abbott Laboratories (NYSE:ABT) announced on February 1st, 2016 the acquisition of Alere (NYSE:ALR). The deal comes just few days after Abbott reported a drop of 15% in its profits for the final quarter… Continue reading